Cargando…

Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis

PURPOSE: With type 2 diabetes mellitus (T2DM) occurring at a younger age, a greater number of women with T2DM experience reproductive health problems. The prevalence of polycystic ovary syndrome (PCOS), a common reproductive disease associated with T2DM, remains unknown in women with T2DM. This syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Caiyi, Feng, Haoyue, Duan, Wen, Chen, Xin, Zhao, Yuemeng, Lan, Ying, Yue, Rensong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471325/
https://www.ncbi.nlm.nih.gov/pubmed/36120432
http://dx.doi.org/10.3389/fendo.2022.980405
_version_ 1784789047823040512
author Long, Caiyi
Feng, Haoyue
Duan, Wen
Chen, Xin
Zhao, Yuemeng
Lan, Ying
Yue, Rensong
author_facet Long, Caiyi
Feng, Haoyue
Duan, Wen
Chen, Xin
Zhao, Yuemeng
Lan, Ying
Yue, Rensong
author_sort Long, Caiyi
collection PubMed
description PURPOSE: With type 2 diabetes mellitus (T2DM) occurring at a younger age, a greater number of women with T2DM experience reproductive health problems. The prevalence of polycystic ovary syndrome (PCOS), a common reproductive disease associated with T2DM, remains unknown in women with T2DM. This systematic review and meta-analysis aimed to determine the prevalence of PCOS in women with T2DM. METHODS: Stata 15.1 was used to perform a meta-analysis on the prevalence of PCOS in patients with T2DM included in this study. Additionally, a narrative review of the effects of different diagnostic methods, obesity, state, and other factors on the prevalence of PCOS was conducted. RESULTS: Meta-analysis showed that the overall prevalence of PCOS in women with T2DM was approximately 21%. Subgroup analysis showed that the incidence of PCOS in female patients aged 25-45 years was higher than that in female patients aged < 25 years. The prevalence of PCOS in obese women was 14%, which was lower than that in normal weight women and normal weight or overweight or obese women. Women with T2DM in Oceania had the highest incidence of PCOS, followed by those in Europe and Asia; women with T2DM in North America had the lowest incidence. In terms of PCOS diagnostic standards, the prevalence of PCOS diagnosed by the National Institutes of Health was the lowest. The prevalence of PCOS diagnosed on the basis of clinical symptoms and biochemical characteristics was the highest, and the prevalence of PCOS diagnosed on the basis of medical records was 20%. CONCLUSIONS: PCOS is a common disease in female patients with T2DM. The prevalence of PCOS in women with T2DM at childbearing age was higher than that in adolescent females. Women with T2DM at childbearing age should pay attention to the screening and prevention of PCOS to avoid the hazards of PCOS to reproductive health. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42022318657.
format Online
Article
Text
id pubmed-9471325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94713252022-09-15 Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis Long, Caiyi Feng, Haoyue Duan, Wen Chen, Xin Zhao, Yuemeng Lan, Ying Yue, Rensong Front Endocrinol (Lausanne) Endocrinology PURPOSE: With type 2 diabetes mellitus (T2DM) occurring at a younger age, a greater number of women with T2DM experience reproductive health problems. The prevalence of polycystic ovary syndrome (PCOS), a common reproductive disease associated with T2DM, remains unknown in women with T2DM. This systematic review and meta-analysis aimed to determine the prevalence of PCOS in women with T2DM. METHODS: Stata 15.1 was used to perform a meta-analysis on the prevalence of PCOS in patients with T2DM included in this study. Additionally, a narrative review of the effects of different diagnostic methods, obesity, state, and other factors on the prevalence of PCOS was conducted. RESULTS: Meta-analysis showed that the overall prevalence of PCOS in women with T2DM was approximately 21%. Subgroup analysis showed that the incidence of PCOS in female patients aged 25-45 years was higher than that in female patients aged < 25 years. The prevalence of PCOS in obese women was 14%, which was lower than that in normal weight women and normal weight or overweight or obese women. Women with T2DM in Oceania had the highest incidence of PCOS, followed by those in Europe and Asia; women with T2DM in North America had the lowest incidence. In terms of PCOS diagnostic standards, the prevalence of PCOS diagnosed by the National Institutes of Health was the lowest. The prevalence of PCOS diagnosed on the basis of clinical symptoms and biochemical characteristics was the highest, and the prevalence of PCOS diagnosed on the basis of medical records was 20%. CONCLUSIONS: PCOS is a common disease in female patients with T2DM. The prevalence of PCOS in women with T2DM at childbearing age was higher than that in adolescent females. Women with T2DM at childbearing age should pay attention to the screening and prevention of PCOS to avoid the hazards of PCOS to reproductive health. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42022318657. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9471325/ /pubmed/36120432 http://dx.doi.org/10.3389/fendo.2022.980405 Text en Copyright © 2022 Long, Feng, Duan, Chen, Zhao, Lan and Yue https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Long, Caiyi
Feng, Haoyue
Duan, Wen
Chen, Xin
Zhao, Yuemeng
Lan, Ying
Yue, Rensong
Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title_full Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title_fullStr Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title_full_unstemmed Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title_short Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
title_sort prevalence of polycystic ovary syndrome in patients with type 2 diabetes: a systematic review and meta-analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471325/
https://www.ncbi.nlm.nih.gov/pubmed/36120432
http://dx.doi.org/10.3389/fendo.2022.980405
work_keys_str_mv AT longcaiyi prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT fenghaoyue prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT duanwen prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT chenxin prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT zhaoyuemeng prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT lanying prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis
AT yuerensong prevalenceofpolycysticovarysyndromeinpatientswithtype2diabetesasystematicreviewandmetaanalysis